Drug Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Drug Screening Market is segmented by Product and Service (Consumables, Instruments, Rapid Testing Devices, and Services), Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples, and Other Samples), End-User (Drug Testing Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, and South America). The report offers the market size and forecasts in value (USD million) for the above segments.

Market Snapshot

Drug Screening Market Size
Study Period: 2019-2027
Base Year: 2021
Fastest Growing Market: Asia-Pacific
Largest Market: North America
CAGR: 12.4 %
Drug Screening Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The Drug Screening Market is expected to register a CAGR of 12.4% during the forecast period.

The impact of the COVID-19 pandemic on the market is expected to be significant. According to a recent survey conducted by the Current Consulting Group (CCG) in August 2020, about 21% of employers have reported a decline of 61% or more in the number of drug tests undertaken on their employees during the pandemic. This is attributed to several factors, including a decrease in the number of people being tested because of an increase in the number of employees working from home and general concerns about workplace drug testing safety and COVID-19 safeguards. Also, as per the research article published in Population Health Management, 2021, a significant decrease in the testing for prescription and illicit drugs was observed, with a weekly test volume decrease of 70%. Thus, decreased drug screening is expected to impact the market during the pandemic.

The key factor driving the global drug screening market are increased drug and alcohol consumption, strict alcohol and drug testing legislation, government funding for pharmaceutical development, and regulatory approvals. According to the World Drug Report 2021 published by United Nations Office on Drugs and Crime (UNODC), the number of people using drugs increased by 22% between 2010 and 2019. As per the UNODC findings, around 200 million people smoked cannabis in 2019, which accounted for 4% of the global population. Furthermore, according to the same source, the number of cannabis users increased by around 18% between 2010 to 2019. In addition, around 20 million people consumed cocaine in 2019, which accounted for 0.4% of the global population. Thus, the rising consumption of drugs among the population is expected to increase the demand for drug screening, in turn, fueling the overall market growth in the studied period.

However, prohibitions on the consumption of alcohol and drugs in some countries, as well as restrictions prohibiting drug testing at work, particularly in developed economies may hinder the global drug screening market's growth.

Scope of the Report

Drug screening is a method for detecting the presence of certain illegal or prescription medications in a person's blood, urine, or other biological samples. The Drug Screening Market is segmented by Product and Service (Consumables, Instruments, Rapid Testing Devices, and Services), Sample Type (Urine Samples, Oral Fluid Samples, Hair Samples, and Other Samples), End-User (Drug Testing Laboratories, Hospitals, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, Africa, and South America). The report offers the market size and forecasts in value (USD million) for the above segments.

By Product and Service
Consumables
Instruments
Rapid Testing Devices
Services
By Sample Type
Urine Samples
Oral Fluid Samples
Hair Samples
Other Samples
By End User
Drug Testing Laboratories
Hospitals
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Urine Sample Segment is Expected to Dominate Over the Forecast Period

Urine testing is one of the most common testing methods for drugs. Benefits associated with urine testing such as noninvasiveness and the ability to detect large numbers of drugs in the sample are expected to drive the segment growth over the forecast period. Urine testing can detect drugs used within 1 to 4 days, sometimes even longer.

Urine drug testing is an important part of monitoring patients with long-term opioid therapy, and it has been suggested for patients receiving long-term benzodiazepine or stimulant therapy too. Also, it is one of the crucial tests to check opioid dependency. Thus, the rising prevalence of opioid overdose is expected to drive market growth over the forecast period. For instance, according to the World Health Organization 2021, opioids include compounds that are extracted from the poppy seed as well as synthetic and semi-synthetic compounds with similar properties that can interact with brain opioid receptors. According to the same source, about 275 million people (or 5.5% of the global population aged 15-64 years) used drugs at least once in 2019 globally. Among them, approximately 62 million people used opioids.

Additionally, as per the research article published in the Journal of Applied Laboratory Medicine, 2020, there has been an increased adoption in the targeted panel of urine drug testing, and the value of clinical urine drug testing was observed to have improved by providing laboratory-based results interpretation and consultative services. Thus, owing to the aforementioned factors, the studied segment is expected to witness healthy growth over the forecast period.

Drug Screening Market Growth

North America Leads the Global Drug Screening Market

North America dominates the drug screening industry due to the serious problem related to high levels of alcohol intake. Also, increasing consumption of illegal drugs, the availability of government funding to combat drug abuse, and the existence of strict rules in the country are encouraging drug screening. For instance, in April 2022, Quest Diagnostics performed drug testing and collected 11 million unidentifiable urine, hair, and oral fluid sample results between January and December 2021. According to Quest Diagnostics' annual drug index data published in March 2022, with 7.5 percent of employees testing were positive for marijuana between January and December 2021. According to the same report, based on over six million urine samples, marijuana had the highest positive rates in the United States workforce increasing by 8.3% in the same period. Hence, the rising consumption of drugs among people is expected to increase the demand for drug screening tests, in turn, benefitting the overall market growth.

Furthermore, various initiatives are being implemented by the United States government to monitor the symptoms and to determine whether a person is under drug abuse. For instance, the Patients and Communities Act of 2018 was a law implemented by the country to counter-acting drug abuse. Thus, the rising drug and alcohol abuse and strict regulations to detect intoxication in the body are expected to help the market growth in the region over the forecast period.

Drug Screening Market Analysis

Competitive Landscape

The key players operating in the global drug screening market are LabCorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Alfa Scientific Designs, Inc., OraSure Technologies, Inc., Siemens Healthineers, Roche, Shimadzu, LifeLock Technologies, Drägerwerk, and Premier Biotech, Inc.

Recent Development

· In September 2020, Labcorp and Infirmary Health announced that they have entered into a multi-year collaboration agreement to provide laboratory services to patients and providers throughout the eastern Gulf Coast region.

· In May 2020, Psychemedics Corporation introduced a Vaping Panel to detect the use of CBD, Marijuana, and Nicotine.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Drug & Alcohol Consumption

      2. 4.2.2 Enforcement of Stringent Laws Mandating Drug & Alcohol Testing

    3. 4.3 Market Restraints

      1. 4.3.1 Ban on Alcohol Consumption in Several Islamic Countries

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 5.1 By Product and Service

      1. 5.1.1 Consumables

      2. 5.1.2 Instruments

      3. 5.1.3 Rapid Testing Devices

      4. 5.1.4 Services

    2. 5.2 By Sample Type

      1. 5.2.1 Urine Samples

      2. 5.2.2 Oral Fluid Samples

      3. 5.2.3 Hair Samples

      4. 5.2.4 Other Samples

    3. 5.3 By End User

      1. 5.3.1 Drug Testing Laboratories

      2. 5.3.2 Hospitals

      3. 5.3.3 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 LabCorp

      2. 6.1.2 Quest Diagnostics

      3. 6.1.3 Abbott Laboratories

      4. 6.1.4 Thermo Fisher Scientific, Inc.

      5. 6.1.5 Alfa Scientific Designs, Inc.

      6. 6.1.6 OraSure Technologies, Inc.

      7. 6.1.7 Siemens Healthineers

      8. 6.1.8 Roche

      9. 6.1.9 Shimadzu

      10. 6.1.10 LifeLoc Technologies

      11. 6.1.11 Dragerwerk

      12. 6.1.12 Premier Biotech, Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Global Drug Screening Market market is studied from 2019 - 2027.

The Global Drug Screening Market is growing at a CAGR of 12.4% over the next 5 years.

Asia-Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

LabCorp, Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Inc., Siemens Healthineers are the major companies operating in Global Drug Screening Market .

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!